lobbying_activities: 761273

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
761273	1b9ae847-fdb1-407d-b345-88e9b406613f	Q1	SHIRE PHARMACEUTICALS LLC	323477	SHIRE PHARMACEUTICALS LLC	2009	first_quarter	PHA	H.R. 1548, Pathway for Biosimilars Act, provisions relating to ultra-orphan biologics. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, provisions relating to ultra-orphan biologics.	HOUSE OF REPRESENTATIVES,SENATE		100000	0	0	2009-04-19T15:54:06-04:00